Martin Shkreli files SEC Form 4 disclosures for Retrophin, Inc.. They have made 43 open-market trades across 2 companies since 2012, most recently 2016-08-26.
CIK 0001293310
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
37 open-market purchases totalling $8.4M since 2012, against 6 sales. Across 33 scored buys the stock is up 1.2% at ninety days, and 0.9 points ahead of the S&P over the same stretch.
33 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -9.6% | +1.2% | +1.2% |
| Alpha | -3.8% | +0.9% | +0.9% |
| Scored | 33 | 33 | 33 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KBIO | SELL | 2016-08-26 | 2016-08-29 | $3.10 | $960K | N/A | N/A | N/A |
| KBIO | SELL | 2016-08-25 | 2016-08-29 | $3.10 | $6.9M | N/A | N/A | N/A |
| KBIO | SELL | 2016-08-25 | 2016-08-29 | $3.10 | $5.9M | N/A | N/A | N/A |
| KBIO | BUY | 2015-11-24 | 2015-11-24 | $38.15 | $191K | N/A | N/A | N/A |
| KBIO | BUY | 2015-11-20 | 2015-11-23 | $18.88 | $94K | N/A | N/A | N/A |
| KBIO | BUY | 2015-11-18 | 2015-11-19 | $2.02 | $889K | N/A | N/A | N/A |
| KBIO | BUY | 2015-11-16 | 2015-11-18 | $1.35 | $1.6M | N/A | N/A | N/A |
| RTRX | SELL | 2014-11-14 | 2014-11-24 | $8.84 | $10.4M | -9.6% | +1.2% | +1.2% |
| RTRX | SELL | 2014-10-01 | 2014-10-09 | $0.01 | $3K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-10-01 | 2014-10-09 | $8.11 | $203K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-09-30 | 2014-10-02 | $9.42 | $38K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-09-19 | 2014-09-23 | $11.15 | $591K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-09-17 | 2014-09-18 | $11.46 | $69K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-09-16 | 2014-09-16 | $10.69 | $80K | -9.6% | +1.2% | +1.2% |
| RTRX | SELL | 2014-05-30 | 2014-06-03 | $15.14 | $4.4M | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-04-04 | 2014-04-07 | $19.64 | $157K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-04-03 | 2014-04-04 | $22.60 | $509K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-04-02 | 2014-04-03 | $22.28 | $241K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-03-24 | 2014-03-27 | $17.61 | $70K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-03-20 | 2014-03-21 | $17.97 | $90K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-03-19 | 2014-03-20 | $18.44 | $65K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-03-14 | 2014-03-17 | $17.36 | $69K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-03-11 | 2014-03-12 | $19.47 | $504K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-03-10 | 2014-03-11 | $19.32 | $207K | -9.6% | +1.2% | +1.2% |
| RTRX | BUY | 2014-03-06 | 2014-03-10 | $18.52 | $75K | -9.6% | +1.2% | +1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.